Who are the top shareholders of the Akums Drugs?

Jul 17 2025 01:27 AM IST
share
Share Via
The top shareholders of Akums Drugs include Akums Master Trust (40.79%), mutual funds (6.11%), foreign institutional investors (5.77%), and Ruby Qc Investment Holdings Pte Ltd (4.62%), with individual investors holding 3.41%. There are no pledged promoter holdings.
The top shareholders of Akums Drugs include the promoters, with Akums Master Trust, represented by Sanjeev Jain and Sandeep Jain, holding the largest share at 40.79%. There are no pledged promoter holdings. Additionally, mutual funds hold a total of 6.11% across 18 schemes, and foreign institutional investors (FIIs) account for 5.77% through 50 different FIIs. The highest public shareholder is Ruby Qc Investment Holdings Pte Ltd, which holds 4.62%. Individual investors collectively own 3.41% of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News